A new study accepted for publication in the journal Transboundary and Emerging Diseases assesses the potential exposure of U.K. deer to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since studies have shown the spill-over of SARS-CoV-2 infections to the Northern American white-tailed deer. If there is a spill-over, wild deer species can act as reservoirs of SARS-CoV-2 with […]
Monthly Archives: March 2022
An implant little bigger than a grain of rice, put gently in place alongside a strategically placed blood vessel, could replace much bulkier devices that stimulate nerves.
Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The […]
Researchers at the Yale Cardiovascular Data Science (CarDS) Lab have developed an artificial intelligence (AI)-based model for clinical diagnosis that can use electrocardiogram (ECG) images, regardless of format or layout, to diagnose multiple heart rhythm and conduction disorders.
Today, the Society for Cardiovascular Angiography & Interventions (SCAI) released an official position statement aimed at providing recommendations to minimize the potential risks involved with medical proctoring. The document, “SCAI Position Statement on Best Practices for Clinical Proctoring of New Technologies and Techniques,” was published today in the Journal of the Society for Cardiovascular Angiography & […]
Researchers discuss the development and structural characterization of therapeutic monoclonal antibodies targeting the surface glycoprotein of filoviruses.
An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.
Researchers determine mucosal SARS-CoV-2-specific antibody levels and their neutralizing effect in pediatric and adult patients.
Researchers analyze commonly available household cleaning products to determine the most effective virucidal agent against SARS-CoV-2.
Researchers discuss the evolution and mechanisms of mutations that have occurred in the spike protein of SARS-CoV-2.